Clinical trial / 1972
Gut flora, including human enterococci, can develop the ability to convert dietary cyclamate into cyclohexylamine.
Tissues and gut contents from animals and a human converter were incubated with [14C]cyclamate to assess its metabolism. Cyclamate was not metabolized by liver, spleen, kidney, or blood, but was converted into cyclohexylamine under anaerobic conditions by caecal, colonic, or rectal contents and faeces from pretreated rats, rabbits, and a human converter. Faeces from the human converter lost activity when cyclamate was removed from the diet. The gut organisms developing the ability to convert cyclamate appear to be clostridia in rats, enterobacteria in rabbits, and enterococci in humans.
- Study type
- Experimental metabolism study (ex vivo and in vivo)
- Who was studied
- Rats, rabbits, guinea pigs, and one human converter
- What was measured
- Metabolism of [14C]cyclamate to cyclohexylamine by tissues and gut flora
THE PAPER
The role of the gut flora in the metabolism of cyclamate.
Drasar BS, Renwick AG, Williams RT. Biochem J, 1972.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.